Preoperative Fasting vs. Not Fasting in Critically Ill Patients

Part of paid clinical trials in Palo Alto, California.

Sponsor
Massachusetts General Hospital
Study ID
NCT06751043
Status
Recruiting

Conditions

  • Critical Illness
  • Fasting
  • Pulmonary Aspiration
  • Surgical Procedure, Unspecified

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Fasting — OTHER
    Process: Fasting pre-procedure Tube feeding will be stopped at least 8 hours before the patient's scheduled surgery or procedure time.
  • Not fasting — OTHER
    Process: Not fasting pre-procedure Tube feeding will be continued until patient transfer to the operating room/procedure area.

Study Details

The goal of this clinical trial is to learn if fasting or not fasting before a procedure has an effect on recovery in those who are critically ill. The main questions it aims to answer for patients on a breathing machine who are receiving tube feeding are: * Does the risk of lung complications and death differ between those who are not fasting, which may have a higher chance of allowing tube feeding to enter the lungs, and fasting, which temporarily stops nutrition before a procedure? * Is there a difference in recovery times, hospital stays, infection rates, need for organ support, safety, and nutrition for those who either fast or do not fast before a procedure? * What is the relationship between nutrition and clinical outcomes? Researchers will compare not fasting and fasting to see if it has an effect on recovery. Participants will: * Be assigned by chance (like a coin toss) to one of two groups. One group (fasting group) will have their tube feeding stopped at least 8 hours before their procedure. The other group (not fasting group) will have their tube feeding stopped right before their procedure. * Be monitored via medical record for amount of protein and calories received, and any complications related to fasting/not fasting. * Receive a phone call from the study team about 3 months after they enter the study to see how they are doing and complete a questionnaire. '

Key Dates

Start date
Apr 28, 2025
Status verified
Jan 2026
Primary completion
Feb 29, 2028
Completion
May 31, 2028

Study Design

Enrollment
1,072 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Active Comparator: Fasting
    Patients randomized to the Fasting arm will have tube feeding stopped at least 8 hours before the scheduled surgery or procedure time.
  • Active Comparator: Not Fasting
    Patients randomized to the Not Fasting arm will have tube feeding continued until transfer to the operating room/procedure area.

Primary Outcome Measure

Days alive and free from mechanical ventilation on postoperative day 28. [ Time Frame: Post-operative day 28 ]

Central Contacts

Locations (19)

FacilityCityStateZIPSite coordinators
Stanford Medical CenterPalo AltoCalifornia94305
Pedro Tanaka, MD, PhD, MACM
(650) 498-6000
UCSF Medical Center ParnassusSan FranciscoCalifornia94143
Lee-lynn Chen, MD
(415) 567-6600
University of Colorado Medical CenterAuroraColorado80045
Ana Fernandez-Bustamante, MD, PhD, FASA
720-848-0000
University of Miami HospitalMiamiFlorida33136
Alexander Fort III, MD
305-243-4000
McGaw Medical Center of NorthwesternChicagoIllinois60611
Ravindra Gupta, MD, FASA, FCCP
(312) 503-7975
Rush University Medical CenterChicagoIllinois60612
Alisha Sachdev, MD
(888) 352-7874
University of Maryland Medical CenterBaltimoreMaryland21201
Megan Anders, MD
(410) 328-8600
Brigham & Women's HospitalBostonMassachusetts02115
Gyorgy Frendl
Mass General HospitalBostonMassachusetts02114
Alex Nagrebetsky
University of Massachusetts Memorial Medical CenterWorcesterMassachusetts01655
Guido Musch, MD, MBA
(508) 334-1000
University of Minnesota Medical CenterMinneapolisMinnesota55455
Benjamin Keith, MD
855-324-7843
Columbia University Irvine Medical CenterNew YorkNew York10032
Vivek Moitra, MD, FASA, FCCP
(212) 305-2500
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065
David Amar, MD
212-639-2000
University of Rochester Medical CenterRochesterNew York14642
Jacob Nadler, MD, PhD, FASA
(585) 275-2100
Montefiore Medical CenterThe BronxNew York10467
Michael Kiyatkin, MD
718-920-4321
Wake Forest University Health SciencesWinston-SalemNorth Carolina27103
Ashish Khanna, MD, FCCP, FCCM
336-758-5000
Cleveland ClinicClevelandOhio44195-
University of Texas Medical BranchGalvestonTexas77555
Marcos Vidal Melo, MD, PhD
409-772-1011
UT Health HoustonHoustonTexas77030
Turan Mehmet, MD
713-486-1000

Find similar trials in Palo Alto, CA

Related Studies